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have some form of disability. For this purpose, we measured brain levels of TNF-a, IL-1b, 
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Neonatal meningitis is an illness characterized by inflammation
of the meninges and occurring within the first 28 days of life.
Being that, this illness remains an important cause of mortality
and morbidity in newborns (de Louvois et al., 2004; Kim, 2010).
The microorganism causing neonatal meningitis varies from
each country; however, a relatively small number of the patho-
gens, such as, Streptococcus agalactiae, Escherichia coli, Listeria
monocytogenes, Haemophilus influenzae type b, Neisseria meningitis
and Streptococcus pneumoniae (Kim, 2010). S. agalactiae is impli-
cated in up to 50% of cases; in developing countries the Gram
negative bacilli accounts for 30–40% (Dawson et al., 1999); being
unusual with the presence of S. pneumoniae 6% and L. mono-
cytogenes 5% (Heath and Okike, 2010). However, pneumococcal
meningitis is the most severe bacterial meningitis. Previous
reports suggest that invasive infection by S. pneumoniae, menin-
gitis and sepsis; in neonatal is associated with prolonged
rupture of membranes, maternal colonization/illness, prema-
turity and high mortality (50%) (Hoffman et al., 2003). The
mortality of untreated patients approaches 100% (Kim, 2010)
and 50% of treated cases have some form of disability (Heath
and Okike, 2010). S. pneumoniae crosses the blood–brain barrier
(BBB) and colonizes the subarachnoid space. Polymorphonuclear
leukocytes (PMN) are the first defense from bacterial infection,
consequently, high amounts of myeloperoxidase (MPO) and
reactive oxygen species (ROS) are produced (Kastenbauer et al.,
2002). Brain cells can also produce cytokines and other pro-
inflammatory molecules in response to bacterial stimuli (van
Furth et al., 1996). It maintains the cascade of host immune
response through the recruitment and activation of the PMN,
matrix metalloproteinase (MMPs) and other pro-inflammatory
mediators that contribute to the BBB breakdown. Although, the
host response is necessary to eliminate the bacteria; undoubt-
edly it is the major cause of brain injury (Heath and Okike, 2010).
TNF-a, IL-1b and IL-6 are cytokines with early response after
pneumococcal recognition and they are associated in pneumo-
coccal meningitis (Mook-Kanamori et al., 2011). Intrathecal
administration of TNF-a resulted in a same pathophysiological
feature of bacterial meningitis and BBB breakdown facilitating
bacterial traversal into the CSF (Rosenberg and Li, 1995) and it
also promoted IL-1b production (Nathan and Scheld, 2000). IL-6
has mainly pro-inflammatory effects and it is a mighty inducer
of fever, leukocytosis and acute-phase protein (Gruol and
Nelson, 1997). Furthermore, cytokine induced neutrophil che-
moattractant-1 (CINC-1) is involved in the infiltration of inflam-
matory cells into the brain parenchyma (Katayama et al., 2009).
It was produced earlier in jugular plasma than in arterial plasma
in meningitis animal model (Barichello et al., 2012a, 2012b).
It maintains the cascade of host immune response through
the recruitment and activation of the PMN, matrix metallo-
proteinase (MMPs) and others pro-inflammatory mediators
that contribute to the BBB breakdown. Although, the host
response is necessary to eliminate the bacteria; undoubtedly
it is the major cause of brain injury (Heath and Okike, 2010).
For this purpose, we measured TNF-a, IL-1b, IL-6, IL-10 and
CINC-1 levels, oxidative damage, enzymatic defense activity
and the blood–brain barrier integrity in neonatal Wistar rats
submitted to pneumococcal meningitis.2. Results
In hippocampus, Fig. 1, the levels of CINC-1 and IL-1b were
increased at 6 h (po0.01; po0.05, respectively), 12 h (po0.05),
24 h (po0.001) and 96 h (po0.001) after pneumococcal menin-
gitis induction. The cytokines IL-6 and IL-10 were not altered
when compared with the control group and TNF-a increased
at 6 h (po0.01), 12 h (po0.001) and 96 h (po0.05).
In cortex, Fig. 2, the CINC-1 levels were increased at 6 h
(po0.05) and 48 h (po0.001). IL-1b was increased at 6 h
(po0.001), 12 h and 24 h (po0.05), moreover, IL-6 was
increased at 0 h (po0.001), 6 h (po0.01) and 12 h (po0.01).
IL-10 and TNF-a were increased only at 6 h (po0.001) and 12 h
(po0.01) after pneumococcal meningitis induction.
We showed in Fig. 3 the oxidative damage and enzymatic
defense activity. TBARS levels were increased at 12 h and 24 h in
the cortex (po0.05); however, in hippocampus the levels did not
change. Protein carbonyl was increased at 24 h and 48 h in the
hippocampus (po0.05). There was an SOD activity increase in
hippocampus at 12 and 48 h (po0.05) and a decrease of the SOD
levels at 24 h (po0.05). CAT activity was increased at 48 h in
hippocampus and in cortex after pneumococcal meningitis
induction (po0.05). The levels in the MPO activity did not
change in hippocampus and cortex after induction, Fig. 4.
The BBB integrity of hippocampus (Fig. 5A) and cortex (Fig. 5B),
were investigated using Evan’s blue dye extravasation. We
observed the BBB breakdown, in hippocampus, within 18 h
and 24 h (po0.05) and in the cortex it started at 12 h until 24 h
after pneumococcal meningitis induction (po0.05).3. Discussion
In this study we showed the influence of the S. pneumoniae in
kinetic cytokine/chemokine, myeloperoxidase activity, oxidative
stress and BBB integrity in two brain regions, hippocampus and
cortex of neonatal rats induced by pneumococcal meningitis.
The neonates brain produced higher levels of cytokine/chemo-
kine, oxidative damage and enzymatic defense in the early
times of this infection. Following this, we observed the BBB
breakdown in the hippocampus and cortex of infected neonates.
In other studies, TNF-a, IL-6 and IL-10 concentrations, as well as,
the granulocyte infiltration showed an increase at 18 h post-
infection in CSF (Sury et al., 2011), and apoptosis occurred in
post-mitotic immature neurons in the dentate gyrus in experi-
mental neonatal pneumococcal meningitis (Grandgirard et al.,
2007a, 2007b). Furthermore, neonatal rats submitted by pneu-
mococcal meningitis presented behavioral deficits in adulthood
(Barichello et al., 2010b).
Bacterial meningitis is a devastating disease during the
neonatal period (Huang et al., 2000), causing a complex and
serious inflammation, that is associated with a high mortality
rate (Hoffman and Maldonado, 2008). Nevertheless, S. pneu-
moniae can replicate rapidly and release cell components into
the CSF. Bacterial cells constituent are recognized by Toll-like
receptors activating the host immune response (Klein et al.,
2006). In consequence, it leads to the activation of nuclear
factor kappa B (NF-Kb) and triggers the expression of inflam-
matory cytokines and polymorphonuclear leukocytes, which
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Fig. 1 – Kinetics of CINC-1, IL-1b, IL-6, IL-10 and TNF-a expression in hippocampus after induction of S. pneumoniae meningitis. The
concentrations of CINC-1, IL-1b, IL-6, IL-10 and TNF-a were obtained in several times at 0, 6, 12, 24, 48 and 96 h after
meningitis induction. Levels of cytokines/chemokine were assessed by ELISA and results are shown as pg of cytokine/
chemokine per 100 mg of tissue. Results show the mean7S.E.M. of 4–6 animals in each group. Symbols indicate statistically
significant when compared with sham group po0.05, po0.01, and po0.001.
b r a i n r e s e a r c h 1 4 7 1 ( 2 0 1 2 ) 1 6 2 – 1 6 8164are attracted to the bloodstream and cross the BBB (Granert
et al., 1994). As a result, large amounts of superoxide anion
and nitric oxide are produced, leading to the formation of
peroxynitrite (Klein et al., 2006) initiating the lipid peroxida-
tion, oxidative protein carbonyls and oxidative stress (Zhang
et al., 2002; Sellner et al., 2010). We found protein carbonyla-
tion only in hippocampus at 24 and 48 h and in cortex we
verified lipid peroxidation in the first hours after induction.
Furthermore, neuronal membrane lipids contain a lot of
highly polyunsaturated fatty acid, mainly in cortical regions
(Halliwell and Gutteridge, 2007). Oxidative stress also leads to
the activation of cytokine/chemokine, matrix metalloprotei-
nase and enhancement of neutrophil activation (Klein et al.,
2006). In our study we found an increase in TNF-a, IL-1b and
CINC-1 in hippocampus at 6 h, and it remained elevated until
96 h after meningitis induction. TNF-a and IL-1b, likewise,
have an important role as early-response cytokines (Nathan
and Scheld, 2000), and are produced after pneumococcal
recognition (Porwoll et al., 1999). In patients, as well as in
the animal meningitis model, the TNF-a has increased early
in the illness course (Brivet et al., 2005; Barichello et al.,
2010c), moreover, TNF-a administration into the CSF results
in the BBB breakdown and generation of a neutrophilic
inflammation (Rosenberg and Li, 1995; Tureen, 1995). IL-1b is
a pro-inflammatory cytokine that mediates some changesrelated with bacterial meningitis, such as, fever, neutrophilia
(Saukkonen et al., 1990) and it is produced by mononuclear
phagocytes, glial cells in the central nervous system (CNS)
through stimulation of bacterial compounds or TNF-a
(Nathan and Scheld, 2000). In addition, another chemokine
involved in the inflammatory cells infiltration into the brain
parenchyma is the CINC-1 (Katayama et al., 2009). In this
study, we verified that CINC-1 levels started to increase
in the first hours in hippocampus and cortex after bacterial
induction. In previous studies, we verified the increase
of the CINC-1 levels at 6 h after meningitis induction
(Barichello et al., 2010c). Furthermore, these levels were
increased first in jugular plasma and then in arterial plasma
in animal model of pneumococcal meningitis suggesting that
its produced in the brain (Barichello et al., 2012a, 2012b).
CINC-1 is a neutrophil chemoattractant and it may be
related to early events in the pneumococcal meningitis
pathophysiology. The cytokines and CINC-1 increase prior
to the BBB breakdown and this breakdown occurred in
hippocampus at 18 h and in cortex at 12 h after pneumococ-
cal meningitis induction. Microorganisms can induce
BBB dysfunction by affecting the release and/or expression
of cytokines, chemokine and cell-adhesion molecules,
which results in increased BBB permeability and pleocytosis
(Kim, 2003).
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Fig. 2 – Kinetics of CINC-1, IL-1b, IL-6, IL-10 and TNF-a expression in cortex after induction of S. pneumoniae meningitis. The
concentrations of CINC-1, IL-1b, IL-6, IL-10 and TNF-a were obtained in several times at 0, 6, 12, 24, 48 and 96 h after
meningitis induction. Levels of cytokines/chemokine were assessed by ELISA and results are shown as pg of cytokine/
chemokine per 100 mg of tissue. Results show the mean7S.E.M. of 4–6 animals in each group. Symbols indicate statistically
significant when compared with Sham group po0.05, po0.01, and po0.001.
b r a i n r e s e a r c h 1 4 7 1 ( 2 0 1 2 ) 1 6 2 – 1 6 8 165There is still the urgent need for new adjunctive treatment
strategies for bacterial meningitis (Tyler, 2008). Although
descriptive, our results demonstrate that during this period,
there was an increase of lipid peroxidation, protein carbony-
lation, cytokines and chemokines.
Neonatal bacterial infections are severe; the interference
with the complex network of cytokines, chemokines, oxi-
dants and other inflammatory mediators may be responsible
for the BBB breakdown and tend to aggravate the illness.4. Experimental procedures
4.1. Infecting organism
S. pneumoniae (serotype 3) was cultured overnight in 10 mL of
Todd Hewitt Broth and then diluted in fresh medium and
grown to logarithmic phase. The culture was centrifuged for
10 min at (5000 g) and resuspended in sterile saline to the
concentration of 1106 cfu/mL. The size of the inoculum was
confirmed by quantitative cultures (Grandgirard et al., 2007a;
Barichello et al., 2010b).4.2. Animal model of meningitis
Neonatal male Wistar rats (15–20 g body weight), postnatal days
3–4, from our breeding colony were used for the experiments.
All procedures were approved by the Animal Care and Experi-
mentation Committee of UNESC, Brazil, and followed in accor-
dance with the National Institute of Health Guide for the Care
and Use of Laboratory Animals (NIH Publications no. 80–23)
revised in 1996. All surgical procedures and bacterial inoculations
were performed under anesthesia, consisting of an intraperito-
neal administration of ketamine (6.6 mg/kg), xylazine (0.3 mg/
kg), and acepromazine (0.16 mg/kg) (Grandgirard et al., 2007a;
Barichello et al., 2010a). Rats underwent a cisterna magna tap
with a 23-gauge needle. The animals received either 10 mL of
sterile saline as a placebo or an equivalent volume of
S. pneumoniae suspension. At the time of inoculation, animals
received fluid replacement and were subsequently returned to
their cages (Irazuzta et al., 2008; Barichello et al., 2010a). Follow-
ing their recovery from anesthesia, animals were fed by their
progenitor. Meningitis was documented by a quantitative culture
of 5 mL of cerebral spinal fluid (CSF) obtained by puncture of the
cisterna magna (Barichello et al., 2010a).
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Fig. 3 – Oxidative damage and enzymatic defense in the rat
brain during development of pneumococcal meningitis. The
concentration of thiobarbituric acid reactive species (TBARS)
(A); protein carbonyls (B); superoxide dismutase (SOD)
activity (C); and catalase (CAT) (D) at 6, 12, 24 and 48 h after
induction. Values are expressed as mean7S.E.M. of 5
animals in each group. Significant difference compared
with Sham group po0.05.
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Fig. 4 – Myeloperoxidase activity in hippocampus and cortex
after S. pneumoniae meningitis induction. The MPO activity
was obtained in several times at 6, 12, 24 and 48 h after
meningitis induction. Results are expressed as
mean7S.E.M. of 5–6 animals in each group. Symbols
indicate statistically significant when compared with sham
group po0.05.
b r a i n r e s e a r c h 1 4 7 1 ( 2 0 1 2 ) 1 6 2 – 1 6 81664.3. Assessment of TNF-a, IL-1b, IL-6, IL-10 and CINC-1
concentrations
Animals were killed by decapitation at different times after
the meningitis induction: 0, 6, 12, 24, 48 and 96 h. The brain
structures hippocampus, cortex and cerebrospinal fluid were
immediately isolated on dry ice and stored at 80 1C for
analysis of the TNF-a, IL-1b, IL-6, IL-10 and CINC-1 levels.
Briefly, hippocampus and cortex were homogenized in
extraction solution containing aprotinin (100 mg of tissue
per 1 mL). The concentration of cytokines/chemokine wasdetermined in hippocampus and cortex using commercially
available ELISA assays, following the instructions supplied by
the manufacturer (DuoSet kits, R&D Systems; Minneapolis).
The results are shown in pg/100 mg of tissue in cortex and in
hippocampus.4.4. Blood–brain barrier permeability to Evan’s blue
The BBB integrity was investigated using Evan’s blue dye
extravasation (Smith and Hall, 1996). The animals were
injected with 1 mL of Evan’s blue at 1% (ip) 1 h before being
killed (Coimbra et al., 2007). The anesthesia consisted of an
intraperitoneal administration of ketamine (6.6 mg/kg), xyla-
zine (0.3 mg/kg), and acepromazine (0.16 mg/kg) (Hoogman
et al., 2007; Grandgirard et al., 2007a). The chest was subse-
quently opened and the brain was transcardially perfused
with 200 mL of saline through the left ventricle at 100 mm Hg
pressured until colorless perfusion fluid was obtained from
the right atrium. Samples were weighed and placed in 50% of
trichloroacetic solution. Following homogenization and cen-
trifugation, the extracted dye was diluted with ethanol (1:3),
and its fluorescence was determined (excitation at 620 nm
and emission at 680 nm) with a luminescence spectrophot-
ometer (Hitachi 650-40, Tokyo, Japan). Calculations were
based on the external standard (62.5–500 ng/mL) in the same
solvent. The EB tissue content was quantified from a linear
standard line derived from known amounts of the dye and it
was expressed per gram of tissue (Smith and Hall, 1996). The
animals were killed at different times at 6, 12, 18, 24 and 30 h
after pneumococcal meningitis induction.4.5. Myeloperoxidase activity
Tissues were homogenized (50 mg/ml) in 0.5% hexadecyltri-
methylammonium bromide and centrifuged at 15,000 g for
40 min. The suspension was then sonicated three times for
30 s. A supernatant aliquot was mixed with a solution of
1.6 mM tetramethylbenzidine and 1 mM H2O2. Activity was
measured spectrophotometrically as the change in absor-
bance at 650 nm at 37 1C (de Young et al., 1989).
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Fig. 5 – The integrity of the blood–brain barrier was investigated
using Evan’s blue dye extravasation in hippocampus and cortex
after induction of S. pneumoniae meningitis. (A) Hippocampus
and (B) cortex were obtained in several times at 6, 12, 18, 24
and 30 h after meningitis induction. The integrity of
blood–brain barrier was assessed by fluorescence was
determined (excitation at 620 nm and emission at 680 nm)
with a luminescence spectrophotometer and results are
shown as ng/mg tissue. Results show the mean7S.E.M. of 5
animals in each group. Symbols indicate statistically
significant when compared with sham group po0.05.
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Animals were killed by decapitation at different times from
meningitis induction: at 6, 12, 24 and 48 h. The brain struc-
tures hippocampus and cortex were immediately isolated on
dry ice and stored at 80 1C for analysis of the thiobarbituric
acid reactive species (TBARS), protein carbonyls, enzymes
superoxide dismutase (SOD) and calatase (CAT). The tissues
0.007 g hippocampus and 0.14 g cortex were homogenized
with a phosphate buffer. The dosages were preformed imme-
diately after homogenization and during the assays. The
samples were under refrigeration and the measurements
were performed in duplicate. The consistent volume of brain
tissue across all the experiments, and it was determined by
protein concentrations measured by the Lowry assay (Lowry
et al., 1951). As an index of lipid peroxidation, we used the
formation of TBARS during an acid-heating reaction (Draper
and Hadley, 1990). Briefly, the samples were mixed with 1 mL
of 10% trichloroacetic acid and 1 mL of 0.67% thiobarbituric
acid and then heated in a boiling water bath for 30 min.TBARS were determined based on absorbance at 532 nm. The
oxidative damage to proteins was assessed by the determina-
tion of carbonyl groups based on the reaction with dinitro-
phenylhidrazine (DNPH), as previously described (Levine
et al., 1990).4.7. Statistics
The variables were shown by mean7S.E.M. of 5–6 animals in
each group. Differences among groups were evaluated by
using analysis of variance (ANOVA) followed by Student–
Newman–Keuls post-hoc test. For cytokine and chemokine
analyses, Student’s t test was used among the different hours
post-infection and sham group. p values o0.05 were consid-
ered statistically significant.Acknowledgments
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